CA125 and Ovarian Cancer: A Comprehensive Review.
Charkhchi P, Cybulski C, Gronwald J, Wong FO, Narod SA, Akbari MR. · 2020
Read CA125 and Ovarian Cancer: A Comprehensive Review. by Charkhchi P, Cybulski C, Gronwald J, Wong FO, Narod SA, Akbari MR. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7763876.txt.
Description
Charkhchi and co-authors review the CA125 blood marker in ovarian cancer. Ovarian cancer is the second most lethal cancer of the female reproductive tract. CA125 has been its main marker for four decades. Yet screening healthy women with it does not save lives, and no major society backs such screening.
The aggressive type II tumors cause most deaths but are seldom caught early. The authors suggest new uses for the marker. Test people with symptoms, not the general public. Raise the cutoff level, and run the test at point of care. Such shifts could catch low-volume type II cancers while surgery can still remove them fully.
Catalog record
| CREATOR | Charkhchi P, Cybulski C, Gronwald J, Wong FO, Narod SA, Akbari MR. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 119 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |